Potential problems in interpretation could be avoided if educational strategies were developed for physicians and patients based on potential outcomes of a trial, Langer added. That's what we tried to do with the tamoxifen trial. Aside from that, it's really quite a challenge to make sure the physician and nursing community is up to speed. Back to top. Rush to release Benefits Critical treatment information gets to physicians and patients faster.
New discoveries reduce fear, offer hope and validate therapy for trial subjects.
Ethical responsibility to disclose outcomes at the earliest possible time is satisfied. Risks Patients might receive a therapy later shown not to be beneficial or even harmful. Information could be publicized before it has undergone peer review. Doctors might not yet be informed enough to adequately counsel patients. The trial's scientific design could be compromised if patients drop out prematurely.